Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[INFORMATION ABOUT DRUGS].

Isabelle Adenot

    Journal International De Bioethique Et D'Ethique Des Sciences
    |November 27, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Poor communication in healthcare erodes patient trust and treatment adherence. The European directive on public drug information highlights the complexities and significance of this issue.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    What value do digital health solutions bring, what are the funding mechanisms and evaluations?

    Therapie·2022
    Same author

    Therapie·2022
    Same author

    Therapie·2020
    Same author

    Therapie·2020
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Chapter 4. Neurotechnologies: striking a balance between scientific progress and privacy

    Journal international de bioethique et d'ethique des sciences·2026
    See all related articles

    Area of Science:

    • Health Communication
    • Patient Adherence
    • Pharmaceutical Policy

    Context:

    • Effective communication is crucial for patient confidence and treatment compliance.
    • The European Union is debating a directive on public information about pharmaceuticals.
    • This debate underscores the intricate nature of drug information dissemination.

    Purpose:

    • To analyze the impact of communication quality on patient outcomes.
    • To examine the challenges and implications of the proposed EU directive on public drug information.
    • To highlight the complexity surrounding public awareness of pharmaceuticals.

    Summary:

    • Adverse communication significantly undermines patient trust and adherence to medical treatments.
    • The ongoing European discourse on a public drug information directive reveals the high stakes involved.

    Related Experiment Videos

  • Navigating the complexities of informing the public about drugs is a critical challenge.

    • Impact:

    • Improving healthcare communication strategies can enhance patient confidence and treatment observance.
    • The EU directive has the potential to reshape how pharmaceutical information is communicated to the public.
    • Addressing communication deficits is vital for better patient engagement and public health outcomes.